Article Text

Download PDFPDF

Highlights from this issue
  1. Jackie A Cassell, Editor in Chief
  1. Brighton and Sussex Medical School, University of Brighton, Falmer, Brighton BN1 9PH
  1. jackiecassell{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

This is the first issue of Sexually Transmitted Infections (STI) in a very special year – 2017 marks the Centenary of a nationwide network of clinics in England and Wales. Together with the British Association for Sexual Health and HIV (BASHH) – of which STI is of course an official journal – we are working to celebrate this important anniversary with a range of specially commissioned content. This month you can begin to read a series of historical vignettes reflecting the history of the journal and the profession, written by eminent physicians and scientists who reflect on a hundred years of progress. We will also be recording podcasts and look forward to joining BASHH at a London celebration in the summer. Make sure to keep an eye on the website and follow us on Twitter.

This journal began in 1925 as the British Journal of Venereal Disease, and you can read early editions on the website. The very first issue covers skin complaints often mistaken for syphilis, the use of bismuth and malaria inoculation to treat syphilis, and the establishment of a network of clinics following a Royal Commission.1 It also discusses diathermy in the treatment of gonorrhoea!

A hundred years ago, we had no effective treatment for gonorrhoea, and it is sobering to realise we may soon be in the same position. The GRASP surveillance system which tracks antimicrobial resistance in England and Wales shows indications that we are not far from ceftriaxone treatment failures in a report by Town et al.2 In an age of nucleic acid based diagnostics, we need alternatives to culture for detecting resistance. A fascinating report by Graham et al reports that whole genome sequencing can be achieved with urine specimens, including the detection of markers associated with resistance.3 On a related note, this month's editorial by Nigel Garrett reflects on the perhaps brief life of syndromic management.4

From its earliest days, the journal has sought to be a resource for clinicians, and for our BASHH readership the Education and Clinical Roundup columns are firm favourites. Dr Sarah Edwards edits the Education (or “How to do it”) column, which aims to reach the parts of clinical practice that guidelines cannot reach. This month for example, we have a useful and informative article by Mason and Winter on the diagnosis and management of aerobic and desquamative inflammatory vaginitis.5 We are always keen to hear about new topics for this series – please do contact Sarah or me with any offers or suggestions.

The newly established clinics of 1916 defined venereal disease as syphilis, gonorrhoea or “soft sore” (chancroid). The range of pathogens has widened, so that we now have the self-sampling techniques for HPV reported in a review by Nelson et al,6 while its epidemiology has been reported in a wide range of populations.7 But the contribution of host and pathogen to disease progression and cure still holds mysteries – for example pelvic inflammatory disease where no pathogen can be detected,8 the impact of HIV and its treatment on anal neoplasia,9 and the serological resolution of syphilis.10

The role of the state and its control of minority populations in STI transmission is certainly a continuing theme from the early journal11 established when homosexuality was both criminalised and victimised. But perhaps the most striking difference between STI and its predecessor is the development of a scientific approach to sexual behaviour, the transmission of infection and its use to inform prophylactic interventions. Pre- and post-exposure prophylaxis for HIV12 ,13 are new clinical challenges requiring sophisticated behavioural science which extends beyond the efficacy of medications into complex interactions of behaviour and context such as serosorting and sexualised drug use.14

I would like to end with my thanks to the editors, reviewers, authors, bloggers and podcasters who make the journal what it is – and thanks are also due to the editorial, production and publishing teams at BMJ who support us so well. The names of 2016's reviewers are published this month, and I am grateful to every one of you. I am also delighted that Adam Bourne has joined us as Associate Editor, while particular thanks must go to Dr Gwenda Hughes who has agreed to join Professor Nicola Low as Deputy Editor in 2017. We are all looking forward to an exciting year in 2017!


View Abstract


  • Competing interests None.

  • Provenance and peer review Commissioned, not peer reviewed.